Concepedia

Publication | Closed Access

ABCG2 inhibitor YHO-13351 sensitizes cancer stem/initiating-like side population cells to irinotecan.

23

Citations

17

References

2013

Year

Yoshiyuki Shishido, Satoshi Ueno, Ryuta Yamazaki, Masato Nagaoka, Takeshi Matsuzaki
PubMed

Abstract

Combination therapy with irinotecan and YHO-13351 would not only accelerate the antitumor effect of this regimen, but also play a crucial role in preventing resistance or relapse.

References

YearCitations

Page 1